This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Zymergen Balance Sheet Health
Financial Health criteria checks 4/6
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$213.56m |
| Equity | US$236.62m |
| Total liabilities | US$234.35m |
| Total assets | US$470.97m |
Recent financial health updates
No updates
Recent updates
Zymergen chief scientific officer to depart as company lays off more employees
Aug 25Zymergen: Ginkgo Bioworks Acquisition
Jul 26Zymergen expands agreement with Octant on developing breakthrough medicines
Jul 14Zymergen Seeks Turnaround But Runway Is Running Low
Jun 03Zymergen: A Humbled Company With A Business On The Ropes
May 23Some Zymergen Inc. (NASDAQ:ZY) Analysts Just Made A Major Cut To Next Year's Estimates
Mar 27
Zymergen Inc. (NASDAQ:ZY) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 25Zymergen: Total Chaos
Dec 09Zymergen: How To Buy A Disaster
Aug 05Analysts Just Made A Major Revision To Their Zymergen Inc. (NASDAQ:ZY) Revenue Forecasts
Aug 05Zymergen acquired Accelerator Life Science Partners’ portfolio company
May 28Financial Position Analysis
Short Term Liabilities: ZY's short term assets ($239.6M) exceed its short term liabilities ($52.2M).
Long Term Liabilities: ZY's short term assets ($239.6M) exceed its long term liabilities ($182.1M).
Debt to Equity History and Analysis
Debt Level: ZY is debt free.
Reducing Debt: ZY had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ZY has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: ZY has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12% each year